| Obese | Control |
---|---|---|
Number of patients | 20 | 5 |
Average age (years) | 59.7 (6.28) | 59.5 (4.76) |
Average BMI (kg/m2) | 36.6 (5.04)** | 21.1 (2.17) |
Average serum concentrations | Â | Â |
   Free IGF-1 (ng/ml) | 4.92 (0.925) | 5.43 (1.80) |
   Insulin (pg/ml) | 742.9 (156.8) | 157.4 (44.1) |
   Interleukin 6 (pg/ml) | 4.6 (0.58)* | 1.6 (0.29) |
   TNF-α (pg/ml) | 7.1 (0.51)* | 4.6 (0.19) |
   Leptin (ng/ml) | 36.6 (4.67)** | 6.40 (3.86) |
   Adiponectin (ug/ml) | 54.5 (6.55)* | 97.5 (32.0) |
Ethnicity/race | Â | Â |
   Hispanic | 12 | 0 |
   White | 6 | 3 |
   African-American | 2 | 0 |
   Asian | 0 | 1 |
   Not Available | 0 | 1 |
Confounding conditions | Â | Â |
   Diabetes | 5 | 0 |
   Hypercholesterolemia | 8 | 0 |
   Hypertension | 14 | 1 |
Medications | Â | Â |
   Aromatase inhibitor | 9 | 1 |
   Tamoxifen | 5 | 2 |
   Chemotherapy | 6 | 2 |
   Metformin | 5 | 0 |
   Statin | 8 | 0 |